Floatz logo

TECHNETIUM TC 99M SESTAMIBI

Cervix Neoplasms

National Cancer Institute (NCI)Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cervix Neoplasms cohort.

Asset / SponsorPhaseRating
Tariquidar
National Cancer Institute (NCI)
Phase 2CCC
Inno-206
The University of Texas Health Science Center, Houston
Phase 2CCC
Alpha-Interferon
The University of Texas Health Science Center, Houston
Phase 2CCC

Same molecule, other indications

TECHNETIUM TC 99M SESTAMIBI is also rated in:

Renal NeoplasmsDormant
B
Indicative ·
57 / 100
View asset →
Ovarian NeoplasmsDormant
CCC
Indicative ·
54 / 100
View asset →
Lung NeoplasmsDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →